Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

This study has been completed.
Information provided by (Responsible Party):
Canadian Cancer Trials Group ( NCIC Clinical Trials Group ) Identifier:
First received: January 28, 2000
Last updated: September 20, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: September 2002 (Final data collection date for primary outcome measure)